Cancer BiologybioRxiv
Therapeutic KRASG12C inhibition drives effective interferon-mediated anti-tumour immunity in immunogenic lung cancers
E. Mugarza, F. van Maldegem, J. Boumelha…·J. Downward
KRASG12C inhibition enhances anti-tumour immunity in immunogenic lung cancers by upregulating interferon signaling through Myc repression, but only synergizes with immune checkpoint blockade in highly immunogenic models.
DOI 10.1126/sciadv.abm8780